Noscapine-Amino Acid Conjugates Suppress the Progression of Cancer Cells.


Journal

ACS pharmacology & translational science
ISSN: 2575-9108
Titre abrégé: ACS Pharmacol Transl Sci
Pays: United States
ID NLM: 101721411

Informations de publication

Date de publication:
09 Dec 2022
Historique:
received: 23 08 2022
entrez: 16 12 2022
pubmed: 17 12 2022
medline: 17 12 2022
Statut: epublish

Résumé

Lung cancer is the leading cause of cancer deaths globally; 1 in 16 people are diagnosed with lung cancer in their lifetime. Microtubules, a critical cytoskeletal assembly, have an essential role in cell division. Interference with the microtubule assembly leads to genetic instability during mitosis and cancer cell death. Currently, available antimitotic drugs such as vincas and taxanes are limited due to side effects such as alopecia, myelosuppression, and drug resistance. Noscapine, an opium alkaloid, is a tubulin-binding agent and can alter the microtubule assembly, causing cancer cell death. Amino acids are fundamental building blocks for protein synthesis, making them essential for the biosynthesis of cancer cells. However, the ability of amino acids in drug transportation has yet to be exploited in developing noscapine analogues as a potential drug candidate for cancer. Hence, in the present study, we have explored the ninth position of noscapine by introducing a hydroxymethylene group using the Blanc reaction and further coupled it with a series of amino acids to construct five target conjugates in good yields. The synthesized amino acid conjugate molecules were biologically evaluated against the A549 lung cancer cell line, among which the noscapine-tryptophan conjugate showed IC

Identifiants

pubmed: 36524011
doi: 10.1021/acsptsci.2c00172
pmc: PMC9745893
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1292-1304

Informations de copyright

© 2022 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

J Chem Theory Comput. 2008 Mar;4(3):435-47
pubmed: 26620784
ACS Pharmacol Transl Sci. 2020 Oct 19;3(6):1318-1329
pubmed: 33344905
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1288-1299
pubmed: 28847179
Pharmacol Ther. 2009 Jan;121(1):29-40
pubmed: 18992769
J Comput Chem. 2011 Jul 15;32(9):2031-40
pubmed: 21469158
Sci Rep. 2019 Dec 20;9(1):19542
pubmed: 31862933
Int J Pharm. 2018 Oct 25;550(1-2):278-289
pubmed: 30149128
Sci Rep. 2018 Nov 16;8(1):16964
pubmed: 30446713
Drug Dev Res. 2022 May;83(3):605-614
pubmed: 34612529
J Pharm Pharmacol. 2020 Nov;72(11):1585-1594
pubmed: 32959391
Proteins. 2013 Dec;81(12):2150-8
pubmed: 24123156
Xenobiotica. 2012 Jul;42(7):603-13
pubmed: 22233275
Cancer Res. 2009 Mar 1;69(5):2126-32
pubmed: 19244126
J Comput Chem. 2005 Dec;26(16):1701-18
pubmed: 16211538
Front Bioeng Biotechnol. 2016 Aug 31;4:69
pubmed: 27630985
Int J Biol Macromol. 2021 Oct 1;188:542-567
pubmed: 34384802
Acta Crystallogr D Biol Crystallogr. 2004 Aug;60(Pt 8):1355-63
pubmed: 15272157
Biol Trace Elem Res. 2021 Apr;199(4):1316-1331
pubmed: 32557113
Artif Cells Nanomed Biotechnol. 2018 Jun;46(4):658-668
pubmed: 28687059
Life Sci. 2020 Oct 1;258:118238
pubmed: 32791146
Eur J Pharm Sci. 2019 Mar 1;129:99-109
pubmed: 30625368
J Chem Inf Model. 2020 Jan 27;60(1):421-433
pubmed: 31873008
Eur J Pharm Sci. 2021 Jan 1;156:105572
pubmed: 32980430
ChemMedChem. 2021 Sep 16;16(18):2882-2894
pubmed: 34159741
Curr Top Med Chem. 2019;18(23):2056-2065
pubmed: 30499389
Mol Pharmacol. 2003 Apr;63(4):799-807
pubmed: 12644580
Int J Clin Pract. 2000 Jul-Aug;54(6):395-8
pubmed: 11092114
Asian J Pharm Sci. 2020 Mar;15(2):192-206
pubmed: 32373199
J Biol Chem. 2002 Oct 18;277(42):39777-85
pubmed: 12183452
Genomics Inform. 2018 Sep;16(3):44-51
pubmed: 30309202
J Biomol Struct Dyn. 2021 Sep 29;:1-18
pubmed: 34583618
Biochem Pharmacol. 2011 Jul 15;82(2):110-21
pubmed: 21501599
Cancer Sci. 2015 Jun;106(6):747-56
pubmed: 25867020
J Biomol Struct Dyn. 2020 Mar;38(5):1335-1353
pubmed: 30957694
ACS Omega. 2019 Dec 03;4(25):21370-21380
pubmed: 31867532
ACS Omega. 2019 Sep 17;4(14):16233-16241
pubmed: 31592173
J Biomol Struct Dyn. 2022 Jan;40(1):101-116
pubmed: 32815796
Cancer Sci. 2016 Mar;107(3):347-52
pubmed: 26749017
Cancer Res. 2015 May 1;75(9):1782-8
pubmed: 25855379
Biomaterials. 2012 Nov;33(33):8461-76
pubmed: 22951103
RSC Adv. 2020 Mar 27;10(21):12626-12652
pubmed: 35497626
Molecules. 2018 Oct 11;23(10):
pubmed: 30314360
Cancer Sci. 2015 Mar;106(3):279-86
pubmed: 25580517

Auteurs

Amardeep Awasthi (A)

Department of Chemistry, University of Delhi, Delhi-110007, India.

Neeraj Kumar (N)

Department of Neurology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois60611, United States.

Abhijeet Mishra (A)

Department of Biochemistry, Shivaji College, University of Delhi, Delhi-110027, India.

Rangnath Ravi (R)

Department of Chemistry, Shivaji College, University of Delhi, Delhi-110027, India.

Anu Dalal (A)

Department of Chemistry, Indian Institute of Technology, Delhi, Delhi-110016, India.

Saurav Shankar (S)

Department of Chemistry, University of Delhi, Delhi-110007, India.

Ramesh Chandra (R)

Department of Chemistry, University of Delhi, Delhi-110007, India.
Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, Delhi-110007, India.
Institute of Nano Medical Sciences, University of Delhi, Delhi-110007, India.

Classifications MeSH